Low-grade Inflammation
8
0
0
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 5 completed trials
Clinical Trials (8)
NutrImmune: Precision Nutrition to Improve Immunity in Individuals With Obesity
Sucralose and Glucose Metabolism in Young Healthy Adults
Individual Factors Related to Chronic Low-grade Inflammation and Cardiometabolic Disease Risk
The Health Effect of Diet Rich in Nordic Berries
Probiotics Against Low Grade Inflammation and Increased Intestinal Permeability in the Elderly
Immune Benefits of Coffee
Effect of Milk Ingredients on Glucose Regulation and Inflammation
Brain-derived Neurotrophic Factor and Cogntive Function